| 0 |
APHAKIC GLAUCOMA |
1 |
0.5000 |
| 1 |
IRIS CYST |
1 |
0.0455 |
| 2 |
ORBITAL CYST |
1 |
0.0385 |
| 3 |
PUPILLARY BLOCK |
1 |
0.0312 |
| 4 |
MANUFACTURING PRODUCTION ISSUE |
1 |
0.0096 |
| 5 |
MYODESOPSIA |
1 |
0.0063 |
| 6 |
CORNEAL INFECTION |
1 |
0.0046 |
| 7 |
PUPILLARY LIGHT REFLEX TESTS ABNORMAL |
1 |
0.0032 |
| 8 |
SUICIDE THREAT |
1 |
0.0026 |
| 9 |
ENDOMETRIAL DISORDER |
1 |
0.0024 |
| 10 |
INTRAOCULAR PRESSURE INCREASED |
27 |
0.0021 |
| 11 |
COMPLICATIONS OF TRANSPLANT SURGERY |
1 |
0.0020 |
| 12 |
HEPATIC ADENOMA |
1 |
0.0019 |
| 13 |
CHOLINERGIC SYNDROME |
1 |
0.0016 |
| 14 |
CORNEAL DISORDER |
3 |
0.0014 |
| 15 |
LEGAL PROBLEM |
1 |
0.0014 |
| 16 |
CORNEAL TRANSPLANT |
1 |
0.0013 |
| 17 |
PRODUCT DROPPER ISSUE |
1 |
0.0013 |
| 18 |
ALTERED VISUAL DEPTH PERCEPTION |
1 |
0.0012 |
| 19 |
PUPILS UNEQUAL |
1 |
0.0009 |
| 20 |
OPTIC NERVE INJURY |
1 |
0.0009 |
| 21 |
RETINAL DISORDER |
2 |
0.0008 |
| 22 |
CORNEAL OPACITY |
1 |
0.0007 |
| 23 |
CONJUNCTIVITIS ALLERGIC |
1 |
0.0007 |
| 24 |
BLINDNESS UNILATERAL |
8 |
0.0006 |
| 25 |
CORNEAL OEDEMA |
1 |
0.0004 |
| 26 |
READING DISORDER |
1 |
0.0004 |
| 27 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 28 |
INSTILLATION SITE PAIN |
1 |
0.0004 |
| 29 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 30 |
ULCERATIVE KERATITIS |
1 |
0.0004 |
| 31 |
RED BLOOD CELL COUNT INCREASED |
1 |
0.0004 |
| 32 |
STRABISMUS |
1 |
0.0003 |
| 33 |
KERATITIS |
1 |
0.0003 |
| 34 |
PHOTOPSIA |
2 |
0.0003 |
| 35 |
GLAUCOMA |
6 |
0.0003 |
| 36 |
VISUAL ACUITY REDUCED |
10 |
0.0003 |
| 37 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV |
1 |
0.0003 |
| 38 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 39 |
MIOSIS |
2 |
0.0002 |
| 40 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0002 |
| 41 |
SELF-INJURIOUS IDEATION |
1 |
0.0002 |
| 42 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 43 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 44 |
EYE PAIN |
13 |
0.0002 |
| 45 |
INCORRECT PRODUCT STORAGE |
3 |
0.0002 |
| 46 |
BLINDNESS |
9 |
0.0002 |
| 47 |
EYE OPERATION |
1 |
0.0002 |
| 48 |
EYE DISORDER |
7 |
0.0002 |
| 49 |
MEDICATION RESIDUE PRESENT |
1 |
0.0002 |
| 50 |
FAECAL INCONTINENCE |
1 |
0.0002 |
| 51 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 52 |
DRUG DISPENSING ERROR |
3 |
0.0002 |
| 53 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 54 |
OCULAR HYPERAEMIA |
8 |
0.0002 |
| 55 |
HEARING IMPAIRED |
1 |
0.0002 |
| 56 |
TENSION |
1 |
0.0002 |
| 57 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 58 |
BLEPHAROSPASM |
1 |
0.0002 |
| 59 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 60 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 61 |
VISUAL IMPAIRMENT |
17 |
0.0001 |
| 62 |
EYE IRRITATION |
7 |
0.0001 |
| 63 |
EYE PRURITUS |
4 |
0.0001 |
| 64 |
FACIAL PAIN |
1 |
0.0001 |
| 65 |
THINKING ABNORMAL |
2 |
0.0001 |
| 66 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 67 |
EYE INFLAMMATION |
1 |
0.0001 |
| 68 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 69 |
PERITONITIS BACTERIAL |
1 |
0.0001 |
| 70 |
EYELID PTOSIS |
1 |
0.0001 |
| 71 |
EYE DISCHARGE |
1 |
0.0001 |
| 72 |
TENDERNESS |
1 |
0.0001 |
| 73 |
INTENTIONAL DRUG MISUSE |
2 |
0.0001 |
| 74 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 75 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 76 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 77 |
EXPIRED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 78 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 79 |
EYE INFECTION |
1 |
0.0001 |
| 80 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 81 |
EYELID OEDEMA |
1 |
0.0001 |
| 82 |
WRIST FRACTURE |
1 |
0.0001 |
| 83 |
PRODUCT COMPLAINT |
2 |
0.0001 |
| 84 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 85 |
HYPOACUSIS |
3 |
0.0001 |
| 86 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 87 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 88 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 89 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 90 |
THIRST |
1 |
0.0001 |
| 91 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
2 |
0.0001 |
| 92 |
PHOTOPHOBIA |
1 |
0.0001 |
| 93 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 94 |
ERUCTATION |
1 |
0.0001 |
| 95 |
VISION BLURRED |
7 |
0.0001 |
| 96 |
SINUS DISORDER |
1 |
0.0001 |
| 97 |
CATARACT |
3 |
0.0001 |
| 98 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 99 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 100 |
PRODUCT QUALITY ISSUE |
6 |
0.0000 |
| 101 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 102 |
DRY EYE |
2 |
0.0000 |
| 103 |
ILLNESS |
4 |
0.0000 |
| 104 |
DIPLOPIA |
1 |
0.0000 |
| 105 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 106 |
FLATULENCE |
2 |
0.0000 |
| 107 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 108 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 109 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 110 |
GAIT INABILITY |
1 |
0.0000 |
| 111 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 112 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 113 |
DYSARTHRIA |
1 |
0.0000 |
| 114 |
POLLAKIURIA |
1 |
0.0000 |
| 115 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 116 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 117 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 118 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 119 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 120 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 121 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 122 |
TINNITUS |
1 |
0.0000 |
| 123 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 124 |
HYPOKALAEMIA |
1 |
0.0000 |
| 125 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 126 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 127 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 128 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 129 |
OEDEMA |
1 |
0.0000 |
| 130 |
HYPONATRAEMIA |
1 |
0.0000 |
| 131 |
SURGERY |
1 |
0.0000 |
| 132 |
DRUG INEFFECTIVE |
22 |
0.0000 |
| 133 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 134 |
VERTIGO |
1 |
0.0000 |
| 135 |
DISCOMFORT |
1 |
0.0000 |
| 136 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 137 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 138 |
RHINORRHOEA |
1 |
0.0000 |
| 139 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 140 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 141 |
UNDERDOSE |
1 |
0.0000 |
| 142 |
PROSTATE CANCER |
1 |
0.0000 |
| 143 |
THROMBOSIS |
1 |
0.0000 |
| 144 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 145 |
TREMOR |
2 |
0.0000 |
| 146 |
MALAISE |
5 |
0.0000 |
| 147 |
MUSCLE SPASMS |
2 |
0.0000 |
| 148 |
ADVERSE EVENT |
1 |
0.0000 |
| 149 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 150 |
CARDIAC DISORDER |
1 |
0.0000 |
| 151 |
CONTUSION |
1 |
0.0000 |
| 152 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 153 |
DYSPEPSIA |
1 |
0.0000 |
| 154 |
HEART RATE INCREASED |
1 |
0.0000 |
| 155 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 156 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 157 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 158 |
HEADACHE |
6 |
0.0000 |
| 159 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 160 |
SEIZURE |
1 |
0.0000 |
| 161 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 162 |
FEELING ABNORMAL |
2 |
0.0000 |
| 163 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 164 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 165 |
DRUG INTERACTION |
1 |
0.0000 |
| 166 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 167 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 168 |
COVID-19 |
1 |
0.0000 |
| 169 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 170 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 171 |
ANAEMIA |
1 |
0.0000 |
| 172 |
SOMNOLENCE |
1 |
0.0000 |
| 173 |
HYPERTENSION |
1 |
0.0000 |
| 174 |
CONSTIPATION |
1 |
0.0000 |
| 175 |
OFF LABEL USE |
4 |
0.0000 |
| 176 |
DEPRESSION |
1 |
0.0000 |
| 177 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 178 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 179 |
WEIGHT DECREASED |
1 |
0.0000 |
| 180 |
DYSPNOEA |
2 |
0.0000 |
| 181 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 182 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 183 |
PAIN |
2 |
0.0000 |
| 184 |
PNEUMONIA |
1 |
0.0000 |
| 185 |
FALL |
1 |
0.0000 |
| 186 |
PYREXIA |
1 |
0.0000 |
| 187 |
NAUSEA |
2 |
0.0000 |
| 188 |
VOMITING |
1 |
0.0000 |
| 189 |
DIZZINESS |
1 |
0.0000 |
| 190 |
DIARRHOEA |
1 |
0.0000 |
| 191 |
FATIGUE |
1 |
0.0000 |